relapsed Classical Hodgkin's Lymphoma

DBCOND0144295Hemic and Lymphatic DiseasesImmunoproliferative Disorders

relapsed Classical Hodgkin's Lymphoma is the indication for 2 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Relapsed Classical Hodgkin Lymphoma
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT830057003MedDRA10086822UMLSC4524752

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for relapsed Classical Hodgkin's Lymphoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In